Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
Feb 25, 2005
filing date -
Feb 27, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A clinically valuable method is provided for evaluating the onset or progression of Alzheimer's disease using a non-invasive biomarker obtained from an independent component analysis (ICA) of an individual's resting state functional MRI. The method is relatively more automated and objective than previous methods and exploits dysfunctional connectivity across an entire network of brain regions in Alzheimer's disease. It eliminates the need for investigator's intervention as much as possible and is more robust than structural and functional methods targeting the hippocampus.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully